TipRanks
4 min read
In This Article:
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly.
-
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
-
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Top 5 Upgrades:
-
Loop Capital upgraded Roku (ROKU) to Buy from Hold with a price target of $100, up from $80. The firm cites expectations that the Amazon.com (AMZN) advertising partnership announced yesterday should begin positively impacting Roku’s financial results starting next year for the upgrade.
-
UBS upgraded Alkermes (ALKS) to Buy from Neutral with a price target of $42, up from $33. The firm says its recent physician survey drives confidence that ALKS-2680 is well positioned to potentially establish itself as an attractive treatment option in narcolepsy idiopathic hypersomnia.
-
Goldman Sachs upgraded Nio (NIO) to Neutral from Sell with a price target of $3.80, up from $3.70. The firm believes management’s cost reduction efforts will help improve the company’s profit levels over the next three years by 4%-10%.
-
Goldman Sachs upgraded XPeng (XPEV) to Buy from Neutral with a price target of $24, up from $16.40. A series of efforts, including organization and supply chain restructuring, technology cost-down, and platformization, have transformed the company’s product and cost structure competitiveness, providing higher visibility for sustainable sales volume growth as well as profit margin improvement, the analyst firm investors.
-
Needham upgraded Cooper Companies (COO) to Buy from Hold with a $94 price target after meeting with management. The firm believes a “dislocation” between the company’s valuation and fundamentals has created an attractive entry point into the shares.
Top 5 Downgrades:
-
Goldman Sachs downgraded Sarepta (SRPT) to Neutral from Buy with a price target of $29, down from $100. The firm sees an “uncertain outlook” amid safety concerns following the second reported death of a non-ambulatory Elevidys-treated Duchenne muscular dystrophy patient due to acute liver failure.
-
KeyBanc downgraded Sunrun (RUN), Enphase Energy (ENPH) and SolarEdge (SEDG) to Underweight from Sector Weight after Senate Republicans last night released a bill that would end tax credits for wind and solar earlier than for other sources.
-
GLJ Research downgraded SolarEdge (SEDG) to Sell from Hold with an unchanged price target of $6.90 following what the firm calls “surprisingly bearish” Senate tax-and-spend bill language.
-
GLJ Research downgraded Sunrun (RUN) to Sell from Hold with a 1c price target following the firm’s analysis of Sunnova Energy’s (NOVA) “hidden ‘second set of books'” and the Senate’s tax-and-spend bill language.
-
Raymond James downgraded Nutrien (NTR) to Market Perform from Outperform with an unchanged price target of $68. The firm cites valuation for the downgrade with the shares up 40% year-to-date.
